Ensign Peak Advisors’s Odyssey Therapeutics ODTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ODTX
Ensign Peak Advisors's ODTX Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Odyssey Therapeutics (ODTX) stake by 25% in Q3 2026, selling an estimated $348K and leaving 48,242 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #786.
Ensign Peak Advisors first reported a position in ODTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.21M in Q2 2026. 73 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.
- Ensign Peak Advisors held 48,242 shares of Odyssey Therapeutics worth $1.07M as of Q3 2026.
- Ensign Peak Advisors sold 16,379 Odyssey Therapeutics shares in Q3 2026, an estimated $348K.
- Odyssey Therapeutics made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q3 2026, its #786 holding.
- Ensign Peak Advisors first reported a position in Odyssey Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Ensign Peak Advisors's Odyssey Therapeutics position peaked at $1.21M in Q2 2026.
- 73 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.